Virulent and certain avirulent strains of BaciUus anthracis harbor a plasmid, designated pXO2, which is involved in the synthesis of capsules. Two classes of rough, noncapsulated (Cap-) variants were isolated from the capsule-producing (Cap') Pasteur vaccine strains ATCC 6602 and ATCC 4229. One class was cured of pXO2, and the other class still carried it. Reversion to Cap' was demonstrable only in rough variants which had retained pXO2. Proof that pXO2 is involved in capsule synthesis came from experiments in which the plasmid was transferred by CP-51-mediated transduction and by a mating system in which plasmid transfer is mediated by a BaciUus thuringiensis fertility plasmid, pX012. Cells of Bacillus cereus and a previously noncapsulated (pXO2-) strain of B. anthracis produced capsules after the acquisition of pXO2.
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Bacillus anthracis requires two virulence factors to cause disease. One of these is a toxin composed of three different proteins known as edema factor, lethal factor, and protective antigen (2, 10, 17) . Mikesell et al. (7) and Robillard et al.
(N. J. Robillard, T. M. Koehler, R. Murray, and C. B. Thorne, Abstr. Annu. Meet. Am. Soc. Microbiol. 1983, H54, p. 115) demonstrated that a 114-megadalton plasmid, formerly referred to as pBA1 but now designated pXO1, is associated with toxin production; Vodkin and Leppla (18) showed by cloning experiments that pXO1 carries the structural genes for protective antigen. The other virulence factor is a capsule composed of D-glutamyl polypeptide (6, 11, 16) . When virulent strains of B. anthracis are grown on media containing serum or bicarbonate or both and incubated in a C02-enriched atmosphere, they produce capsules and the colonies appear mucoid. In the absence of serum or bicarbonate, they fail to produce capsules and the colonies appear rough. Thus, colonies of mutants which cannot make capsules can be easily distinguished from colonies of the capsulated parental cells and are readily isolated by selection of rough sectors or outgrowth from mucoid colonies grown on medium containing bicarbonate.
It was reported that the heat-attenuated Pasteur vaccine strains ofB. anthracis, which form capsules but are avirulent because they are unable to produce toxin, were devoid of plasmid DNA (7) . However, it has been shown recently that the Pasteur vaccine strains ATCC 6602 and ATCC 4229 do contain a capsule plasmid which has been designated pXO2 filtration of a 9% solution) at a final concentration of 0.7% (wt/vol) and with horse serum (GIBCO Laboratories, Grand Island, N.Y.) at a final concentration of 10% (voUvol). BHI medium contained 37 g of brain heart infusion (Difco) per liter. L broth contained 10 g of tryptone (Difco), 5 g of yeast extract (Difco), and 10 g of NaCl per liter with the pH adjusted to 7.0. R medium has been described previously (8 Toxin assays. Lethal factor and edema activities were assayed as described previously (7) .
Detection of plasmid DNA. Plasmid DNA was extracted by a modification of the procedure described by Kado and Liu (3) . Cells for plasmid extraction were grown in 250-ml Erlenmeyer flasks containing 25 ml of BHI broth. Cultures were incubated for 16 h at 37°C on a rotary shaker (100 to 160 rpm). Cells from 25 ml of culture were collected by centrifugation at 10,000 rpm in a Sorvall SS34 rotor for 10 min at 15°C and suspended in 1 7.9] ) by gentle vortexing. Cells were lysed by adding 1 ml of the suspension to 2 ml of lysis buffer prepared by adding 3 g of sodium dodecyl sulfate and S ml of 3 N NaOH to 100 ml of 15% (wt/vol) sucrose in 0.05 M Tris-hydroxide. The tubes were rapidly inverted 20 times to mix the cells and buffer and were then held in a 60°C water bath for 30 min. Pronase (0.5 ml; Calbiochem-Behring, La Jolla, Calif.) solution (2 mg/ml in 2 M Tris [pH 7.0]) was added, and the tubes were mixed as described above and incubated in a 37°C water bath for 20 min. The lysate was extracted with 6 ml of phenol-chloroform (1:1, vol/vol) by inverting the tubes 40 times. The Transduction of pXO2. Bacteriophage CP-51 was propagated on B. anthracis 6602 and assayed on B. cereus 569. Recipient cells for transduction were grown in 250-ml Erlenmeyer flasks containing 25 ml of L broth (for B. cereus) or BHI broth with 0.5% (wt/vol) glycerol (for B. anthracis) and were incubated at 37°C on a rotary shaker at 250 rpm. Cells from a 10% (vol/vol) transfer of a 16-h culture were grown for 5 h. Cells (0.1 ml containing ca. 108 CFU) and phage (0.1 ml containing ca. 5 x 109 PFU) were spread together on NBY agar containing bicarbonate. Plates were incubated at 37°C in 20% CO2. After 3 h, 0.1 ml of phage CP-54 (3 x 109 PFU) was spread on the transduction plates to lyse noncapsulated cells and to allow the selection of capsulated transductants. Incubation in CO2 was continued for 36 to 48 h.
Transfer of plasmids by mating. Matings were performed as described by Battisti et al. (1) . RESULTS Plasmid analysis of B. anthracis strains. A number of virulent and avirulent strains of B. anthracis were analyzed for plasmid content. All virulent strains examined, which included NH, Ames, Colorado, Buffalo, and Vollum 1B, carried two plasmids, as shown in Fig. 1 , lane 1, for Vollum 1B. In addition to pXO1, they contained a second, smaller plasmid which has been designated pXO2. Strains could be cured of pXO2 by growing them in the presence of novobiocin. A total of 3,000 to 5,000 colonies each of strains NH, Ames, and Vollum 1B obtained from cultures treated with novobiocin were screened for capsule formation and protective antigen synthesis on immunoassay agar. All colonies produced protective antigen, as evidenced by the halos (Fig. 4) 49, 1985 carbonate and C02, the colonies were rough and could not be distinguished from colonies of pXO2-strains.
The size of pXO2, estimated to have a molecular mass of about 60 megadaltons based on its rate of migration in agarose gels, is probably very close to the maximum size of DNA that can be packaged by CP-51. Previously, a value of ca. 60 megadaltons was found for the molecular mass of CP-51 DNA (19) .
Transfer of pXO2 to B. cereus by mating. To transfer pXO2 to B. cereus, we also made use of the Bacillus mating system in which plasmid transfer is mediated by the B. thuringiensis fertility plasmid, pXO12 (1). pXO12 was transferred from B. thuringiensis subsp. thuringiensis 4042A UM8 td2(pXO12, pBC16) to B. cereus 569 UM20-1 Strr. Tcr transcipients of B. cereus were selected on L agar containing streptomycin (200 ,ug/ml) and tetracycline (25 jig/ml) and screened by phase microscopy for the presence of parasporal crystals, a phenotypic characteristic of pXO12+ cells (1) . A B. cereus transcipient, 569 UM20-1 tr202-1, which inherited both pXO12 and pBC16, was then mated with B. anthracis 4229 UM12 Nalr, and Tcr transcipients were selected on NBY agar containing tetracycline (5 pug/ml) and nalidixic acid (30 gug/ml). Approximately 50% of the Tcr transcipients also inherited the fertility plasmid, pXO12. One of these, B. anthracis 4229 UM12 tr299-3(pXO2, pXO12, pBC16), was used as the donor for transferring pXO2 to B. cereus 569 UM20-1. Mating mixtures were plated on NBY agar supplemented with bicarbonate, horse serum, streptomycin, and tetracycline. The plates were incubated in 20% CO2. After In view of the demonstration that rough variants which still carry pXO2 are able to revert to Cap+, it will be interesting to determine whether the mutations that engender the rough phenotype are chromosome or plasmid borne. We plan to test this by transferring pXO2 from rough pXO2+ variants to strains that have been cured of the plasmid.
